1. Role of miR-647 in human gastric cancer suppression
   Wenlong Cao et al, 2017 CrossRef
2. Perspective on the dynamics of cancer
   Youcef Derbal, 2017, Theor Biol Med Model CrossRef
3. PET/Computed Tomography and Precision Medicine
   Charles Marcus et al, 2017, PET Clinics CrossRef
4. HER2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks
   Chen Xu et al, 2017, Histopathology CrossRef
5. Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report
   Yasuhiro Arakawa et al, 2017 CrossRef
6. Lauren classification and individualized chemotherapy in gastric cancer
   JUNLI MA et al, 2016 CrossRef
7. Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations
   C. Böger et al, 2017 CrossRef
8. Overexpression of FIBCD1 Is Predictive of Poor Prognosis in Gastric Cancer
   Chunyi Jiang et al, 2018 CrossRef
9. Porphyrin modified trastuzumab improves efficacy of HER2 targeted photodynamic therapy of gastric cancer
   Barbara Korsak et al, 2017, Int. J. Cancer CrossRef
10. Paclitaxel reversed trastuzumab resistance via regulating JUN in human gastric cancer cells identified by FAN analysis
    Zhe Wang et al, 2018, Future Oncology CrossRef
11. Heat Shock Factor 1 Predicts Poor Prognosis of Gastric Cancer
    Seok-Jun Kim et al, 2018, Yonsei Med J CrossRef
12. Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
    Jiang Lv et al, 2019, J Hematol Oncol CrossRef
13. Remifentanil regulates proliferation and apoptosis of gastric cancer cells by regulating miR-206/GOLPH3
    Xiao-Jun Chen et al, 2019, WCJD CrossRef
14. TRP channels in gastric cancer: New hopes and clinical perspectives.
    Andra M Sterea et al, 2019, Cell Calcium CrossRef
15. High-Expression HBO1 Predicts Poor Prognosis in Gastric Cancer
    Yan Wang et al, 2019 CrossRef
16. PELP1 is a novel oncogene in gastric tumorigenesis and negatively regulated by miR-15 family microRNAs
    Chuanyu Ma et al, 2019, CBM CrossRef
17. microRNA‐95 knockdown inhibits epithelial–mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by upregulating DUSP5
    Mei  Du et al, 2019, J Cell Physiol CrossRef
18. Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) levels in the cerebrospinal fluid of children with influenza-associated encephalopathy
    Shinichiro Morichi et al, 2017, Journal of Infection and Chemotherapy CrossRef
19. High expression of Wls is associated with lymph node metastasis and advanced TNM stage in gastric carcinomas
    Wei Zhang et al, 2017, Pathol Int CrossRef
20. HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer
    Li Wei et al, 2019, Human Cell CrossRef
21. In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells
    Tetsuo Mashima et al, 2019, Br J Cancer CrossRef
22. MFAP2 is overexpressed in gastric cancer and promotes motility via the MFAP2/integrin α5β1/FAK/ERK pathway
    Li-wen Yao et al, 2020, Oncogenesis CrossRef
23. Activation of the LINC00242/miR-141/FOXC1 axis underpins the development of gastric cancer
    Xiongdong Zhong et al, 2020, Cancer Cell Int CrossRef
24. Expression of transmembrane protein 41A is associated with metastasis via the modulation of E‑cadherin in radically resected gastric cancer
    Bin Lin et al, 2018, Mol Med Report CrossRef
25. Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment
    Chen Xu et al, 2019, Aging CrossRef
26. Identification of UAP1L1 as tumor promotor in gastric cancer through regulation of CDK6
    Jing Qi et al, 2020, Aging CrossRef
27. Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancers
    He Zhang et al, 2020, Pathology - Research and Practice CrossRef
28. Long Noncoding RNAs: New Regulators of Resistance to Systemic Therapies for Gastric Cancer
    Weihong Sun et al, 2021, BioMed Research International CrossRef
29. Circular RNA CDR1as Inhibits the Metastasis of Gastric Cancer through Targeting miR-876-5p/GNG7 Axis.
    Jiajia Jiang et al, 2021, Gastroenterol Res Pract CrossRef
30. Comparison of Conventional and Advanced Echocardiographic Techniques in Early Detection of Cardiotoxicity in Patients Undergoing Cancer Chemotherapy
    HN Pradeep et al, 2018, Indian Journal of Medical and Paediatric Oncology CrossRef
31. TMSB10, a potential prognosis prediction biomarker, promotes the invasion and angiogenesis of gastric cancer
    ZhenKun Yan et al, 2021, Journal of Gastroenterology and Hepatology CrossRef
32. NDUFC1 Is Upregulated in Gastric Cancer and Regulates Cell Proliferation, Apoptosis, Cycle and Migration
    Liang Xu et al, 2021, Front. Oncol. CrossRef
33. FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohort
    Thorben Schrumpf et al, 2022, PLoS ONE CrossRef
34. Glutamate-cysteine ligase catalytic and its modifier function as novel immunotargets in gastric adenocarcinoma
    Dezhuan Da et al, 2022, Asian Journal of Surgery CrossRef
35. Serum inflammatory cytokines comparison in gastric cancer therapy
    Li Zhang et al, 2019 CrossRef
36. Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China
    Chen Xu et al, 2022, Diagn Pathol CrossRef
37. miR‑4735‑3p inhibits cell migration and invasion of gastric cancer by downregulating NEDD9
    Yanchun Ma, 2022, Oncol Lett CrossRef
38. Thermo-Transient Receptor Potential Channels: Therapeutic Potential in Gastric Cancer
    Gang-Fan Zong et al, 2022, IJMS CrossRef
39. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer
    Ya-Kun Jiang et al, 2024, World J Gastrointest Oncol CrossRef
40. Claudin18.2-Targeted SPECT/CT Imaging for Gastric Cancer: Preclinical Evaluation and Clinical Translation of the 99mTc-Labeled Nanobody (PHG102) Radiotracer
    Zhidong Bai et al, 2024, ACS Pharmacol. Transl. Sci. CrossRef
41. The Chinese Herbal Formula Weichang'an Reduces the Proliferation of Human Gastric Cancer Cells via Mitochondrial Apoptosis
    Weixia Chen et al, 2024, Chinese medicine and natural products CrossRef
42. Synthesis, preclinical evaluation and pilot clinical translation of [68Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancer
    Rongxi Wang et al, 2024, Eur J Nucl Med Mol Imaging CrossRef
43. Gastric Cancer Signaling Pathways and Therapeutic Applications
    Mingfang Wu et al, 2024, Technol Cancer Res Treat CrossRef